U.S. Supreme Court to Hear Vape Ban Case; Former FDA Deputy Commissioner Joins Vape Industry's Defense

Nov.29.2024
U.S. Supreme Court to Hear Vape Ban Case; Former FDA Deputy Commissioner Joins Vape Industry's Defense
The U.S. Supreme Court will decide on the flavor ban for vapes, with the FDA advocating for the ban's continuation, while vape companies express opposition. Former FDA Deputy Commissioner has joined the defense, representing the interests of the vape industry.

According to a report from the New York Post on November 28, the issue of vapes will be brought before the Supreme Court next week. Federal regulatory agencies are requesting Supreme Court support for their ban on flavored e-cigarette products, which aims to combat the significant increase in youth vape use.

 

The Food and Drug Administration (FDA) has rejected marketing applications for over a million candy or fruit-flavored products. Advocates say this measure will help reduce the rate of youth vape use after a surge in 2019 that reached "epidemic levels." 

 

However, vape companies argue that the FDA is ignoring their arguments that flavored e-cigarette products help adults quit smoking and do not increase the risk for teenagers.

 

In September, Donald Trump took to social media to vow to "save" vapes, but his administration may take a different approach moving forward.

 

On Monday (25th), the Supreme Court heard an appeal from the FDA against a ruling by the Fifth Circuit Court of Appeals in the United States. Despite other courts supporting the FDA's decision, the Appeals Court sided with Triton Distribution. It overturned a ruling that banned the sale of nicotine e-liquids (such as "Jimmy The Juice Man in Peachy Strawberry"). Triton stated that the FDA unfairly changed its requirements without sufficient advance notice.

 

"It sort of pulls the chair out from the applicants," said Marc Scheineson, a former FDA associate commissioner and attorney who now represents other small electronic tobacco companies.

 

The FDA's regulation progress in the vape market has been slow, with illegal flavored e-cigarettes still widely available. The FDA has approved some tobacco-flavored vapes, and recently approved the first mint-flavored e-cigarette for use by adult smokers.

 

Dennis Henigan, Vice President of Legal and Regulatory Affairs for the Smoke-Free Kids Campaign, pointed out that by combining bans on tobacco products with enforcement of age restrictions at the federal and state levels, youth nicotine use has been reduced to its lowest levels in a decade.

 

The FDA's requirement is clear: it is concerned that a court ruling could lead to flavored vapes becoming even more popular. Flavored vapes are the primary choice for 1.6 million high school students still using e-cigarettes, and this could pose a serious threat to public health.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Special Report|Haypp’s Nicotine Pouch Volumes Rise 40%: Who Controls the Digital Shelf for Modern Oral?
Haypp Group reported a 40% year-on-year increase in nicotine pouch volumes in the first quarter of 2026, with U.S. and U.K. volumes rising 123% and 102%, respectively. Haypp says around 97% of its consumer traffic is organic and that its Media & Insights business provides brand owners with on-site visibility, trial activation and consumer intelligence. For international tobacco companies, Haypp may be both a growth partner for modern oral products and a new source of channel leverage.
Special Report
May.22
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
KT&G Overseas Tobacco Revenue Jumps 24.6%, Attracting Global Capital
KT&G Overseas Tobacco Revenue Jumps 24.6%, Attracting Global Capital
South Korean tobacco company KT&G is drawing growing global investor attention after reporting record overseas tobacco sales, with international institutions including Capital Group and BlackRock increasing their stakes.
Business
May.19
VEEV Arrives in South Korea, Completing PMI’s IQOS-ZYN-VEEV Portfolio
VEEV Arrives in South Korea, Completing PMI’s IQOS-ZYN-VEEV Portfolio
Philip Morris Korea has officially launched its VEEV e-vapor brand in South Korea, introducing both the VEEV inPRIME device and VEEBI inPRIME pods. The launch further expands PMI’s smoke-free portfolio in Korea, alongside its IQOS heated tobacco products and ZYN nicotine pouches.
Jun.16
 Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
According to Reuters, Philip Morris International (PMI) lowered its 2026 adjusted earnings-per-share forecast amid regulatory uncertainty around Zyn nicotine pouches, rising competition and shipment pressure in the U.S. market.
PMI
Jun.02